Angelini Pharma acquires ThermaCare® from GSK

Mar 08, 2020 499

Angelini Pharma announces today it has acquired the ThermaCare® global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia. The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence.

Heat therapy is widely known to help ease muscle pain, reduce soreness, and loosen tight muscles. ThermaCare® use patented technology that produces real heat to help body rebuild damaged tissue and accelerate healing. ThermaCare® products are formulated for: Lower Back & Hip, Neck, Wrist & Shoulder, Knee & Elbow, Multi-Purpose Muscle, Multi-Purpose Joint and Menstrual.

Read more


You may be interested